Admission screening testing of patients and staff N95 respirators are cost-effective in reducing COVID-19 hospital-acquired infections.

MLA

McAndrew, F., et al. “Admission Screening Testing of Patients and Staff N95 Respirators Are Cost-Effective in Reducing COVID-19 Hospital-Acquired Infections.” The Journal of Hospital Infection, vol. 152, Oct. 2024, pp. 81–92. EBSCOhost, https://doi.org/10.1016/j.jhin.2024.06.015.

APA

McAndrew, F., Abeysuriya, R. G., Sacks-Davis, R., Sammann, M., Lister, D. M., West, D., Majumdar, S. S., & Scott, N. (2024). Admission screening testing of patients and staff N95 respirators are cost-effective in reducing COVID-19 hospital-acquired infections. The Journal of Hospital Infection, 152, 81–92. https://doi.org/10.1016/j.jhin.2024.06.015

Chicago

McAndrew, F, R G Abeysuriya, R Sacks-Davis, M Sammann, D M Lister, D West, S S Majumdar, and N Scott. 2024. “Admission Screening Testing of Patients and Staff N95 Respirators Are Cost-Effective in Reducing COVID-19 Hospital-Acquired Infections.” The Journal of Hospital Infection 152 (October): 81–92. doi:10.1016/j.jhin.2024.06.015.